Economic Evaluations of Digital Health Interventions for the Management of Musculoskeletal Disorders: Systematic Review and Meta-Analysis.

Autor: Fatoye F; Department of Health Professions, Manchester Metropolitan University, Manchester, United Kingdom.; Lifestyle Diseases Research Entity, North West University, Potchefstroom, South Africa., Gebrye T; Department of Health Professions, Manchester Metropolitan University, Manchester, United Kingdom., Mbada C; Department of Health Professions, Manchester Metropolitan University, Manchester, United Kingdom., Useh U; Lifestyle Diseases Research Entity, North West University, Potchefstroom, South Africa.
Jazyk: angličtina
Zdroj: Journal of medical Internet research [J Med Internet Res] 2023 Jul 06; Vol. 25, pp. e41113. Date of Electronic Publication: 2023 Jul 06.
DOI: 10.2196/41113
Abstrakt: Background: Musculoskeletal disorders (MSDs) are widespread in many countries and their huge burden on the society has necessitated innovative approaches such as digital health interventions. However, no study has evaluated the findings of cost-effectiveness of these interventions.
Objective: This study aims to synthesize the cost-effectiveness of digital health interventions for people with MSDs.
Methods: Electronic databases including MEDLINE, AMED, CIHAHL, PsycINFO, Scopus, Web of Science, and Centre for Review and Dissemination were searched for cost-effectiveness of digital health published between inception and June 2022 following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. References of all retrieved articles were checked for relevant studies. Quality appraisal of the included studies was performed using the Quality of Health Economic Studies (QHES) instrument. Results were presented using a narrative synthesis and random effects meta-analysis.
Results: A total of 10 studies from 6 countries met the inclusion criteria. Using the QHES instrument, we found that the mean score of the overall quality of the included studies was 82.5. Included studies were on nonspecific chronic low back pain (n=4), chronic pain (n=2), knee and hip osteoarthritis (n=3), and fibromyalgia (n=1). The economic perspectives adopted in the included studies were societal (n=4), societal and health care (n=3), and health care (n=3). Of the 10 included studies, 5 (50%) used quality-adjusted life-years as the outcome measures. Except 1 study, all the included studies reported that digital health interventions were cost-effective compared with the control group. In a random effects meta-analysis (n=2), the pooled disability and quality-adjusted life-years were -0.176 (95% CI -0.317 to -0.035; P=.01) and 3.855 (95% CI 2.023 to 5.687; P<.001), respectively. The meta-analysis (n=2) for the costs was in favor of the digital health intervention compared with control: US $417.52 (95% CI -522.01 to -313.03).
Conclusions: Studies indicate that digital health interventions are cost-effective for people with MSDs. Our findings suggest that digital health intervention could help improve access to treatment for patients with MSDs and as a result improve their health outcomes. Clinicians and policy makers should consider the use of these interventions for patients with MSDs.
Trial Registration: PROSPERO CRD42021253221; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=253221.
(©Francis Fatoye, Tadesse Gebrye, Chidozie Mbada, Ushotanefe Useh. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 06.07.2023.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje